"Navigating the Modern News Zoo so you don't have to."
Thursday, January 23, 2025
FDA approves nasal spray for treatment-resistant depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants, according to a news release issued by Johnson & Johnson.
👉 Full Story
Can KETO fix Diabetes? (the VIRTA story)
- How To Sell Digital Downloads On Etsy? 9 Steps Guide - Aamir Zahoor
- 5 Ultra-Processed Foods You Can Actually Feel OK About Eating, According to Experts - Sarah Garone
- Model Criticized for Dancing Next to Elderly Boyfriend’s Hospital Bed After Being Added to His Will - Isaiah Amos
- Study finds the average American spent 2.5 months on their phone in 2024
- Amid a flurry of hype, Microsoft reorganizes entire dev team around AI - Samuel Axon
- Plex update adds public reviews and profiles - Anna Washenko
Migrants Self Deporting Before Trump Takes Office
- Rumors Surround Prince Harry and Sarah Ferguson Meeting in New York - Isaiah Amos
- Jhanak Written Update Today 13th Aug 2024: Jhanak’s Stunning Decision in the Final Showdown - Aaradhana Chaurasia
- The United States Space Force Gears Up for X-37B Launch - Arya Chandran
- Vitamin D and keloid scars: Researchers find inhibiting enzyme could lead to treatment
- Samsung Unpacked: Samsung teased an extra-thin S25 model at Unpacked - Brian Heater
- Worth the wait: Deborah Rice flourishes in nursing career after putting her plans on hold - Jerry.Grimes@ecuhealth.org
